Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Auton

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Chemical Research in Toxicology|January 1, 1996
Characterization of the interaction of 2-[2-nitro-4-(trifluoromethyl)benzoyl]-4,4,6,6,-tetramethyl- cyclohexane-1,3,5-trione with rat hepatic 4-hydroxyphenylpyruvate dioxygenaseM K Ellis, A C Whitfield, L A Gowans, et al.
Journal of Computer-Aided Molecular Design|March 1, 1997
PRO_SELECT: combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. TechnologyC W Murray, D E Clark, T R Auton, et al.
Journal of Inherited Metabolic Disease|September 5, 1998
From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drugE A Lock, M K Ellis, P Gaskin, et al.
British Journal of Clinical Pharmacology|December 4, 2003
Evaluation of two carrier protein-angiotensin I conjugate vaccines to assess their future potential to control high blood pressure (hypertension) in manM R Downham, T R Auton, A Rosul, et al.
British Journal of Pharmacology|March 22, 2000
Active immunization with angiotensin I peptide analogue vaccines selectively reduces the pressor effects of exogenous angiotensin I in conscious ratsS M Gardiner, T R Auton, M R Downham, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Chemical Research in Toxicology|January 1, 1996
Characterization of the interaction of 2-[2-nitro-4-(trifluoromethyl)benzoyl]-4,4,6,6,-tetramethyl- cyclohexane-1,3,5-trione with rat hepatic 4-hydroxyphenylpyruvate dioxygenaseM K Ellis, A C Whitfield, L A Gowans, et al.
Journal of Computer-Aided Molecular Design|March 1, 1997
PRO_SELECT: combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. TechnologyC W Murray, D E Clark, T R Auton, et al.
Journal of Inherited Metabolic Disease|September 5, 1998
From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drugE A Lock, M K Ellis, P Gaskin, et al.
British Journal of Clinical Pharmacology|December 4, 2003
Evaluation of two carrier protein-angiotensin I conjugate vaccines to assess their future potential to control high blood pressure (hypertension) in manM R Downham, T R Auton, A Rosul, et al.
British Journal of Pharmacology|March 22, 2000
Active immunization with angiotensin I peptide analogue vaccines selectively reduces the pressor effects of exogenous angiotensin I in conscious ratsS M Gardiner, T R Auton, M R Downham, et al.
Pageof 3